Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 193Session 2025-2026

Sub for SB 193 by Committee on Public Health and Welfare - Exempting law enforcement agencies who do not provide emergency opioid antagonists pursuant to the statewide protocol from the requirement to procure a physician medical director.

As Introduced

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. SB 193›
    2. SB 193 — As Introduced

    Kansas Legislature

    SB 193 — As Introduced

    picture_as_pdf Download PDF Session of 2025SENATE BILL No. 193By Committee on Public Health and Welfare2-41AN ACT concerning the state board of pharmacy; relating to emergency 2opioid antagonists; removing law enforcement agencies and officers 3from the board's statewide opioid antagonist protocol; amending K.S.A. 42024 Supp. 65-16,127 and repealing the existing section.56Be it enacted by the Legislature of the State of Kansas:7Section 1. K.S.A. 2024 Supp. 65-16,127 is hereby amended to read as 8follows: 65-16,127. (a) As used in this section:9(1) "Bystander" means a family member, friend, caregiver or other 10person in a position to assist a person who the family member, friend, 11caregiver or other person believes, in good faith, to be experiencing an 12opioid overdose.13(2) "Emergency opioid antagonist" means any drug that inhibits the 14effects of opioids and that is approved by the United States food and drug 15administration for the treatment of an opioid overdose.16(3) (A) "First responder" includes any emergency medical service 17provider, as defined by K.S.A. 65-6112, and amendments thereto, any law 18enforcement officer, as defined by K.S.A. 22-2202, and amendments 19thereto, and any actual member of any organized fire department, whether 20regular or volunteer.21(B) "First responder" does not include any law enforcement officer, 22as defined in K.S.A. 22-2202, and amendments thereto.23(4) (A) "First responder agency" includes, but is not limited to, any 24law enforcement agency, fire department or criminal forensic laboratory of 25any city, county or the state of Kansas.26(B) "First responder agency" does not include any law enforcement 27agency.28(5) "Opioid antagonist protocol" means the protocol established by 29the state board of pharmacy pursuant to subsection (b).30(6) "Opioid overdose" means an acute condition including, but not 31limited to, extreme physical illness, decreased level of consciousness, 32respiratory depression, coma, mania or death, resulting from the 33consumption or use of an opioid or another substance with which an 34opioid was combined, or that a layperson would reasonably believe to be 35resulting from the consumption or use of an opioid or another substance 36with which an opioid was combined, and for which medical assistance is 1required.2(7) "Patient" means a person believed to be at risk of experiencing an 3opioid overdose.4(8) "School nurse" means a professional nurse licensed by the board 5of nursing and employed by a school district to perform nursing 6procedures in a school setting.7(9) "Healthcare provider" means a physician licensed to practice 8medicine and surgery by the state board of healing arts, a licensed dentist, 9a mid-level practitioner as defined by K.S.A. 65-1626, and amendments 10thereto, or any person authorized by law to prescribe medication.11(b) The state board of pharmacy shall issue a statewide opioid 12antagonist protocol that establishes requirements for a licensed pharmacist 13to dispense emergency opioid antagonists to a person pursuant to this 14section. The opioid antagonist protocol shall include procedures to ensure 15accurate recordkeeping and education of the person to whom the 16emergency opioid antagonist is furnished, including, but not limited to: 17Opioid overdose prevention, recognition and response; safe administration 18of an emergency opioid antagonist; potential side effects or adverse events 19that may occur as a result of administering an emergency opioid 20antagonist; a requirement that the administering person immediately 21contact emergency medical services for a patient; and the availability of 22drug treatment programs.23(c) A pharmacist may furnish an emergency opioid antagonist to a 24patient or bystander subject to the requirements of this section, the 25pharmacy act of the state of Kansas and any rules and regulations adopted 26by the state board of pharmacy thereunder.27(d) A pharmacist furnishing an emergency opioid antagonist pursuant 28to this section may not permit the person to whom the emergency opioid 29antagonist is furnished to waive any consultation required by this section 30or any rules and regulations adopted thereunder.31(e) Any first responder, scientist or technician operating under a first 32responder agency or school nurse is authorized to possess, store, distribute 33and administer emergency opioid antagonists as clinically indicated, 34provided that all personnel with access to emergency opioid antagonists 35are trained, at a minimum, on the following:36(1) Techniques to recognize signs of an opioid overdose;37(2) standards and procedures to store, distribute and administer an 38emergency opioid antagonist;39(3) emergency follow-up procedures, including the requirement to 40summon emergency ambulance services either immediately before or 41immediately after administering an emergency opioid antagonist to a 42patient; and43(4) inventory requirements and reporting any administration of an 1emergency opioid antagonist to a healthcare provider.2(f) (1) Any first responder agency electing to provide an emergency 3opioid antagonist to its employees or volunteers for the purpose of 4administering the emergency opioid antagonist shall procure the services 5of a physician to serve as physician medical director for the first responder 6agency's emergency opioid antagonist program.7(2) The first responder agency shall utilize the physician medical 8director or a licensed pharmacist for the purposes of:9(A) Obtaining a supply of emergency opioid antagonists;10(B) receiving assistance developing necessary policies and 11procedures that comply with this section and any rules and regulations 12adopted thereunder;13(C) training personnel; and14(D) coordinating agency activities with local emergency ambulance 15services and medical directors to provide quality assurance activities.16(g) (1) Any healthcare provider or pharmacist who, in good faith and 17with reasonable care, prescribes or dispenses an emergency opioid 18antagonist pursuant to this section shall not, by an act or omission, be 19subject to civil liability, criminal prosecution or any disciplinary or other 20adverse action by a professional licensure entity arising from the 21healthcare provider or pharmacist prescribing or dispensing the emergency 22opioid antagonist.23(2) Any patient, bystander, school nurse, law enforcement officer, as 24defined in K.S.A. 22-2202, and amendments thereto, or a first responder, 25scientist or technician operating under a first responder agency, who, in 26good faith and with reasonable care, receives and administers an 27emergency opioid antagonist pursuant to this section to a person 28experiencing a suspected opioid overdose shall not, by an act or omission, 29be subject to civil liability or criminal prosecution, unless personal injury 30results from the gross negligence or willful or wanton misconduct in the 31administration of the emergency opioid antagonist.32(3) Any first responder agency or law enforcement agency employing 33or contracting any person that, in good faith and with reasonable care, 34administers an emergency opioid antagonist pursuant to this section to a 35person experiencing a suspected opioid overdose shall not, by an act or 36omission, be subject to civil liability, criminal prosecution, any 37disciplinary or other adverse action by a professional licensure entity or 38any professional review.39(h) The state board of pharmacy shall adopt rules and regulations as 40may be necessary to implement the provisions of this section prior to 41January 1, 2018.42(i) This section shall be a part of and supplemental to the pharmacy 43act of the state of Kansas.1Sec. 2. K.S.A. 2024 Supp. 65-16,127 is hereby repealed.2Sec. 3. This act shall take effect and be in force from and after its 3publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 Page 3 Page 4 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:53 PM 11/14/2026

    Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.